-
1
The potential role for regulatory T-cell therapy in vascularized composite allograft transplantation.
Published 2014“…Lippincott Williams and Wilkins…”
Journal article -
2
Bridging innate with adaptive immunity in transplantation: triggers, sensors, and modulators.
Published 2014“…Lippincott Williams and Wilkins…”
Journal article -
3
Modulation of CD27/CD70 co-stimulatory pathway may allow for the generation of a more potent human regulatory T cell product for cell therapy
Published 2017“…Lippincott, Williams & Wilkins…”
Conference item -
4
B cells and antibodies in transplantation
Published 2016“…Lippincott Williams & Wilkins…”
Journal article -
5
Predictors of cancer risk in the long-term solid-organ transplant recipient.
Published 2014“…Lippincott Williams and Wilkins…”
Journal article -
6
Application of operational tolerance signatures are limited by variability and type of immunosuppression in renal transplant recipients: A cross-sectional study.
Published 2016“…Lippincott, Williams and Wilkins…”
Journal article -
7
CD45RA distinguishes CD4+CD25+CD127−/low TSDR demethylated regulatory T cell subpopulations with differential stability and susceptibility to tacrolimus-mediated inhibition of supp...
Published 2017“…Lippincott, Williams & Wilkins…”
Journal article -
8
How to escape the immune response: what tumours have to teach to transplant immunologists?
Published 2017“…Lippincott, Williams & Wilkins…”
Journal article -
9
Tolerance: one transplant for life.
Published 2014“…Lippincott Williams and Wilkins…”
Journal article